Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Registered Direct Offering	IPO	Additional paid-in capital	Additional paid-in capital Registered Direct Offering	Additional paid-in capital IPO	Accumulated deficit	Accumulated other comprehensive income	Class A common stock	Class A common stock Common Stock	Class A common stock Common Stock Registered Direct Offering	Class A common stock Common Stock IPO
Beginning balance (in shares) at Dec. 31, 2022										11,773,065
Beginning balance at Dec. 31, 2022	$ 253,705			$ 1,378,125			$ (1,124,421)	$ 0		$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(175,767)						(175,767)
Common stock issued pursuant to stock option exercises (in shares)										50,444
Common stock issued pursuant to stock option exercises	285			285
Stock-based compensation expense	(326)			(326)
Vested restricted stock units converted to common stock (in shares)										431,671
Other comprehensive income, net of tax	425							425
Issuance of common stock in offering, net of issuance costs (in shares)											676,868	12,315,752
Issuance of common stock in offering, net of issuance costs		$ 7,564	$ 135,439		$ 7,564	$ 135,438						$ 1
Issuance of common stock for first Milestone Payment (in shares)										701,460
Issuance of common stock for first Milestone Payment	$ 6,692			6,692
Fractional shares issued upon reverse stock split (in shares)										29,603
Ending balance (in shares) at Dec. 31, 2023	25,978,863									25,978,863
Ending balance at Dec. 31, 2023	$ 228,017			1,527,778			(1,300,188)	425		$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(52,286)						(52,286)
Common stock issued pursuant to stock option exercises (in shares)									68,453	68,453
Common stock issued pursuant to stock option exercises	394			394
Common stock issued pursuant to Perceptive warrant exercise (in shares)										645,414
Common stock issued pursuant to Perceptive warrant exercise	12,586			12,586
Stock-based compensation expense	9,138			9,138
Vested restricted stock units converted to common stock (in shares)										471,663
Other comprehensive income, net of tax	405							405
Issuance of common stock in offering, net of issuance costs (in shares)										825,379
Issuance of common stock in offering, net of issuance costs	46,496			46,496
Common stock issued pursuant to employee stock purchase plan (in shares)										26,773
Common stock issued pursuant to employee stock purchase plan	$ 497			497
Ending balance (in shares) at Dec. 31, 2024	28,016,545									28,016,545
Ending balance at Dec. 31, 2024	$ 245,247			$ 1,596,889			$ (1,352,474)	$ 830		$ 2